(68Ga)Ga-FAPI-46 PET/MRT unveils lymph node metastases and changes treatment strategy in recurrent advanced high-grade serous ovarian carcinoma patient
High-grade serous ovarian carcinoma (HGOC) is frequently diagnosed at an advanced stage, leading to high recurrence rates. This case report highlights the utility of [68Ga]Ga-FAPI-46 PET/MRI in detecting previously unidentified lymph node metastases in a 75-year-old woman with recurrent HGOC, which...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
September 2025
|
| In: |
Clinical nuclear medicine
Year: 2025, Volume: 50, Issue: 9, Pages: 873-874 |
| ISSN: | 1536-0229 |
| DOI: | 10.1097/RLU.0000000000005871 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/RLU.0000000000005871 Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/nuclearmed/abstract/2025/09000/_68ga_ga_fapi_46_pet_mrt_unveils_lymph_node.17.aspx |
| Author Notes: | Marie Prochiner, MS, Anna Hinterberger, MD,Björn Wängler, Frederik Marmé, MD, Freba Grawe, MD |
| Summary: | High-grade serous ovarian carcinoma (HGOC) is frequently diagnosed at an advanced stage, leading to high recurrence rates. This case report highlights the utility of [68Ga]Ga-FAPI-46 PET/MRI in detecting previously unidentified lymph node metastases in a 75-year-old woman with recurrent HGOC, which altered the treatment strategy. The imaging revealed increased [68Ga]Ga-FAPI-46 uptake in nonenlarged mediastinal and left perihilar lymph nodes, reclassifying the patient from FIGO IIIb to FIGO stage IV and prompting a change in therapeutic management. |
|---|---|
| Item Description: | Im Titel steht der Ausdruck [68Ga] in eckigen Klammern, 68 ist dabei hochgestellt Gesehen am 20.11.2025 |
| Physical Description: | Online Resource |
| ISSN: | 1536-0229 |
| DOI: | 10.1097/RLU.0000000000005871 |